Abstract:The protein transient receptor potential melastatin type 8 (TRPM8), a non-selective, calcium (Ca2+)-permeable ion channel is implicated in several pathological conditions, including neuropathic pain states. In our previous research endeavors, we have identified β-lactam derivatives with high hydrophobic character that exhibit potent and selective TRPM8 antagonist activity. This work describes the synthesis of novel derivatives featuring C-terminal amides and diversely substituted N'-terminal monobenzyl groups in an attempt to increase the total polar surface area (TPSA) in this family of compounds. The primary goal was to assess the influence of these substituents on the inhibition of menthol-induced cellular Ca2+ entry, thereby establishing critical structure-activity relationships. While the substitution of the tert-butyl ester by isobutyl amide moieties improved the antagonist activity, none of the N'-monobencyl derivatives, regardless of the substituent on the phenyl ring, achieved the activity of the model dibenzyl compound. The antagonist potency of the most effective compounds was subsequently verified using Patch-Clamp electrophysiology experiments. Furthermore, we evaluated the selectivity of one of these compounds against other members of the transient receptor potential (TRP) ion channel family and some receptors connected to peripheral pain pathways. This compound demonstrated specificity for TRPM8 channels. To better comprehend the potential mode of interaction, we conducted docking experiments to uncover plausible binding sites on the functionally active tetrameric protein. While the four main populated poses are located by the pore zone, a similar location to that described for the N-(3-aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thienylmethyl)-benzamide (AMTB) antagonist cannot be discarded. Finally, in vivo experiments, involving a couple of selected compounds, revealed significant antinociceptive activity within a mice model of cold allodynia induced by oxaliplatin (OXA).

N-[4-(Methylsulfonylamino)benzyl]thiourea Analogues As Vanilloid Receptor Antagonists: Analysis of Structure–activity Relationships for the ‘C-Region’

<i>N</i>-(3-Acyloxy-2-benzylpropyl)-<i>N</i>‘-[4-(methylsulfonylamino)benzyl]thiourea Analogues: Novel Potent and High Affinity Antagonists and Partial Antagonists of the Vanilloid Receptor

Analysis of Structure–activity Relationships for the ‘B-Region’ of N -(3-acyloxy-2-benzylpropyl)- N ′ -[4-(methylsulfonylamino)benzyl]thiourea Analogues As Vanilloid Receptor Antagonists: Discovery of an N -Hydroxythiourea Analogue with Potent Analgesic Activity

Analysis of Structure-Activity Relationships for the 'A-Region' of N-(4-T-Butylbenzyl)-N '-[4-(methylsulfonylamino)benzyl]thiourea Analogues As Trpv1 Antagonists

Analysis of structure-activity relationships with the N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism.

High-affinity Partial Agonists of the Vanilloid Receptor.

Rational Design and Validation of a Vanilloid-Sensitive TRPV2 Ion Channel.

High Affinity Antagonists of the Vanilloid Receptor.

A Set of Novel Capsaicin Analogs As Molecular Ruler for Conformational Change of the TRPV1 Ligand-Binding Pocket

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Design, Synthesis and Functional Validation of Peptide Inhibitors Based on TRPV1 Ion Channel Agonist RhTx.

Non-vanillyl Resiniferatoxin Analogues As Potent and Metabolically Stable Transient Receptor Potential Vanilloid 1 Agonists

Discovery of N -(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists

Structure activity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) analogues as potent opioid receptor ligands: preliminary results on the role of electronic characteristics for affinity and function.

In silico research to assist the investigation of carboxamide derivatives as potent TRPV1 antagonists

Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects in Vivo Based on the Functional Conversion Induced by Altering the Orientation of the Indazole Core.

Three-Dimensional Quantitative Structure-Activity Relationship Study of Transient Receptor Potential Vanilloid 1 Channel Antagonists Reveals Potential for Drug Design Purposes

Study of Some Substituted Quinolines as Transient Receptor Potential Vanilloid 1 Inhibitors by the in silico and in vivo Method

β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity

Identification of novel selective TRPV3 antagonists based on virtual screening, molecular docking and bioassay

Attenuation of thermal nociception and hyperalgesia by VR1 blockers